Events

Introduction to the Digital Europe Programme
JUN
Tue
10
10:00 - 11:30

This was 1 month ago

Location

Online

Programmes
Digital Europe HPC AI Continent Cybersecurity Advanced Digital Skills Deployment: Best use of technologies Semiconductors

DEP4ALL, the NCP Network for the Digital Europe Programme (DEP), organises a series of online training sessions for potential DEP applicants

The first session, "Introduction to the Digital Europe Programme", will focus on 

  • The role of DEP in the EU’s digital strategy
  • Key IT/digital terms – explained simply
  • DEP priority areas and project types
  • How to get started on the EU Funding & Tenders Portal
  • Practical tips for new applicants

Registration for this session is open via this link.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.